Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 Cases (1987-1998)

Journal of the American Veterinary Medical Association

Volumn 224, Issue 1, 2004, Pages 79-82

  Hahn, Kevin A ^a   King, Glen K ^a   Carreras, Janet K ^a  

^a Gulf Coast Veterinary Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW METASTASIS; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; DOG; DOG DISEASE; EXTERNAL EAR; FEMALE; INTESTINE METASTASIS; LIVER METASTASIS; MALE; MASTOCYTOMA; METASTASIS; NONHUMAN; PERINEUM; PREPUCE; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; SPLEEN METASTASIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR GROWTH;

ANIMALS; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; FEMALE; MALE; MAST-CELL SARCOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS; PINNA;

EID: 0347511745     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2004.224.79     Document Type: Article

References (30)

1. Dorn ER, Taylor D, Schneider R, et al. Survey of animal neoplasms in Alameda and Contra Costa counties, California. J Natl Cancer Inst 1968;40:307-318.
2. Cohen D, Reif SS, Brodey RS, et al. Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Res 1974;34:2859-2868.
3. Bostock DE. The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 1973;14:27-40.
4. Patnaik AK, Ehler WJ, MacEwen EG. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984;21:469-474.
5. Turrel JM, Kitchell BE, Miller LM, et al. Prognostic factors for radiation treatment of mast cell tumors in 85 dogs. J Am Vet Med Assoc 1988;193:936-940.
6. Kravis LD, Vail DM, Kisseberth WC, et al. Frequency of argyrophilic nucleolar organizer regions in fine-needle aspirates and biopsy specimens and biopsy specimens from mast cell tumors in dogs. J Am Vet Med Assoc 1996;209:1418-1420.
7. Bostock DE, Crocker J, Harris K, et al. Nucleolar organiser regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumors. Br J Cancer 1989;59:915-918.
8. Ayl RD, Couto CG, Hammer AS, et al. Correlation of DNA ploidy to tumor histologic grade, clinical variables, and survival in dogs with mast cell tumors. Vet Pathol 1992;29:386-390.
9. Simoes JPC, Schoning P, Butine M. Prognosis of canine/mast cell tumors: a comparison of three methods. Vet Pathol 1994;31:637-647.
10. Miller DM. The occurrence of mast cell tumors in young Shar Peis. J Vet Diagn Invest 1995;7:360-363.
11. Ginn PE, Fox LE, Brower JC, et al. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors. Vet Pathol 2000;37:33-39.
12. Jaffe MH, Hosgood G, Taylor HW, et al. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors. Vet Pathol 2000;37:40-46.
13. Fan TM, Kitchell BE. Retrospective analysis of oral mast cell tumors in dogs, in Proceedings. 19th Annu Vet Cancer Soc Conf 1999:40.
14. Takahashi T, Kadosawa T, Nagase M, et al. Visceral mast cell tumor in dogs: 10 cases (1982-1997). J Am Vet Med Assoc 2000;216:222-226.
15. Michels GM, Knapp DW, DeNicola DB, et al. Prognosis following surgical excision of canine cutaneous mast cell tumors with histologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. J Am Anim Hosp Assoc 2002;38:458-466.
16. McManus PM. Frequency and severity of mastocytemia in dogs with and without mast cell tumors: 120 cases (1995-1997). J Am Vet Med Assoc 1999;215:355-357.
17. Rassnick KM, Moore AS, Williams LE, et al. Treatment of canine mast cell tumors with CCNU (lomustine). J Vet Intern Med 1999;13:601-605.
18. Ogilvie GK, Moore AS. Mast cell tumors. In: Ogilvie GK, Moore AS, eds. Managing the veterinary cancer patient: a practice manual. Trenton, NJ: Veterinary Learning Systems, 1995;503-514.
19. Thamm DJ, Mauldin EA, Vail DM. Prednisone and vinblastine chemotherapy for canine mast cell tumor-41 cases (1992-1997). J Vet Intern Med 13;5:491-497.
20. Consultation on the biological behavior and therapy of tumors of domestic animals. Geneva: World Health Organization, 1978.
21. EJ Hall. Time, dose, and fractionation in radiotherapy. In: Hall EJ, ed. Radiobiology for the radiologist. 4th ed. Philadelphia: JB Lippincott Co, 1994;211-230.
22. Freidman LM, Furberg CD, DeMets DL. Survival analysis. In: Freidman LM, ed. Fundamentals of clinical trials. 2nd ed. Littleton, Mass: PSG Publishing Co Inc, 1985;191-200.
23. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
24. Cox DR. Regression models and life-tables. J Roy Stat Soc 1972;34:187-220.
25. Al-Sarraf R, Mauldin GN, Patnaik AK, et al. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. J Vet Intern Med 1996;10:376-378.
26. Weisse C, Shofer FS, Sorenmo K. Recurrence rates and sites for Ggrade II canine cutaneous tumors following complete surgical excision. J Am Anim Hosp Assoc 2002;38:71-73.
27. Frimberger AE, Moore AS, LaRue SM, et al. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993). J Am Anim Hosp Assoc 1997;33:320-324.
28. LaDue T, Price GS, Dodge R, et al. Radiation therapy for incompletely resected canine mast cell tumors. Vet Radiol Ultrasound 1998;39:57-62.
29. Chaffin K, Thrall DE. Results of radiation therapy in 19 dogs with cutaneous mast cell tumors and regional lymph node metastasis. Vet Radiol Ultrasound 2002;43:392-395.
30. Gerritsen RJ, Teske E, Kraus JS, et al. Multi-agent chemotherapy for mast cell tumors in the dog. Vet Q 1998;20:28-31.